Dactus 2 MG


Dactus 2 MG


Stock Status:

In Stock

  • *Upload Prescription

    • (max file size 80 MB)






Glimepiride is demonstrated in taking after conditions-
  • Glimepiride is demonstrated as an aide to slim down and work out to lower the blood glucose in patients with noninsulin subordinate (Sort II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by count calories and work out alone.
  • Glimepiride may be utilized concomitantly with metformin when eat lesswork out, and Glimepiride or metformin alone does not result in satisfactory glycaemic control.
  • Glimepiride is additionally demonstrated for utilize in combination with affront to lower blood glucose in patients whose hyperglycaemia cannot be controlled by count calories and work out in conjunction with an verbal hypoglycaemic agent. Combined utilize of
  • Glimepiride and affront may increment the potential for hypoglycaemia.


Glimepiride may be a sulfonylurea antidiabetic specialist which diminishes blood glucose concentration. The essential instrument of activity of Glimepiride shows up to be subordinate on fortifying the discharge of affront from working pancreatic beta cells. Glimepiride acts in concert with glucose by moving forward the affectability of beta cells to physiological glucose jolt, coming about in affront emission. In expansion, extrapancreatic impacts like lessening of basal hepatic glucose generation, expanded fringe tissue affectability to affront and glucose take-up may too play part within the action of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic activity of a single dosage of Glimepiride holds on for 24 hours.


Dosage and Administration

In rule, the measurement of Glimepiride is represented by the specified blood sugar level. The dose of Glimepiride must be the lowest which is adequate to attain the required metabolic control. The starting and the upkeep dosages are set based on the comes about of customary check of glucose in blood and peeChecking of glucose levels in blood and pee too serves to distinguish either essential or auxiliary disappointment of therapy.

  • Introductory dosage and dosage titration: the regular introductory dosage is 1 mg once day by dayin the event that fundamental, the every day measurements can be expanded. Any increment can be based on standard blood sugar observing, and ought to be slow, i.e., at interims of 1 to 2 weeks, and carried out stepwise, as takes after: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.
  • Dosage in patients with well controlled diabetes: the regular measurements run in patients with well controlled diabetes is 1 to 4 mg daily.
  • Distribution of dosages: Timing and dispersion of dosages are chosen by the doctor, in thought of the patient’s current life-style. Ordinarily, a single every day dosage is adequate. This ought to be taken quickly some time recently a considerable breakfast or in case none is taken quickly some time recently the primary fundamental supper. It is exceptionally vital not to skip dinners after taking the medicate.
  • Secondary measurement alteration: As control of diabetes makes stridesaffectability to insuiin incrementshence, Glimepiride necessity may drop as treatment continues. To maintain a strategic distance from hypoglycaemia, opportune dosage decrease or cessation of Glimepiride treatment must be considered. A dosage alteration must moreover be considered at whatever point the patient’s weight or life-styie changes, or other variables emerge which cause an expanded vulnerability to hypo or hyperglycaemia.


Based on encounter with Glimepiride and known intuitive for other sulfonylureas, the taking after intuitive must be considered.

In expansion to affront and other verbal antidiabetic specialists, drugs which may potentiate the hypoglycaemic activity of Glimepiride incorporate: Expert inhibitors, aminosalicylic corrosive, anabolic steroids and male sex hormones, azapropazone, chloramphenicol, ciofibrate, coumarin subordinates, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluconazole, fluoxetine, guanethidine, ifosfamide, MAO-inhibitors, miconazole, oxpentifylline (tall measurements parenteral), oxyphenbutazone, para-aminosalicylic corrosive, phenylbutazone, probenecid, quinolones, salicylates, sulphinpyrazone, sulfonamide anti-microbials, tetracyclines, tritoqualine, trofosfamide.
Drugs which may constrict the hypoglycaemic activity of Glimepiride include: 

  • Acetazoiamide, barbiturates, calcium channel blockers, corticosteroids, diazoxide, diuretics, glucagon, isoniazid, purgatives, nicotinic corrosive (tall measurements), oestrogens, phenothiazines, phenytoin, progestagens, rifampicin, sympathomimetic specialists, thyroid hormones.
  • H2 receptor opponents, beta-blockers, clonidine and reserpine may lead to either potentiation or debilitating of the blood-glucose-lowering effect.
  • Concomitant treatment with a beta-receptor blocker, clonidine, guanethidine or reserpine may cover the caution side effects of a hypoglycaemic attack.
  • Acute and persistent aicohol admissions may either potentiate or constrict the action of Glimepiride in an erratic design.



Glimepiride isn’t appropriate for the treatment of affront subordinate (sort I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be utilized in patients easily affected to Glimepiride, other sulfonylureas, other sulfonamides, extreme hepatic brokennessserious disability of renal work and dialysis patients.


Side Effects

Hypoglycaemia, transitory visual impedancesicknessspewingthe runsstomach torment, urticaria, drop in blood weight.


Pregnancy & Lactation

Glimepiride must not be taken amid pregnancy; a changeover to affront is vital. Patients arranging a pregnancy must educate their doctor, and ought to alter over to affront. Ingestion of Glimepiride with breast drain bolstering may hurt the child. Subsequently, Glimepiride must not be taken by breastfeeding ladies. Either a changeover or total cessation of breastfeeding is vital.


Precautions & Warnings

Within the introductory weeks of treatment, the hazard of hypoglycaemia may be expanded and requires cautious observing. In the event that such chance display it may be fundamental to alter the measurement of Glimepiride, Hypoglycaemia can nearly be instantly controlled by prompt admissions of carbohydrates (glucose or sugar).


Therapeutic Class



Storage Conditions

Keep below 30°C temperature, secured from light & dampness. Keep out of the reach of children.


Pharmaceutical Name

ACME Laboratories Ltd.